Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicentre,Prospective,Randomized,Open Label,Blinded-endpoint Trial for Reperfusion Enhancement After Completing Thrombectomy Using Intraarterial Thrombolysis(REACT-IA-Thrombolysis Domain)Embedded in A Multi-faCtorial,mulTi-arm, Multi-staGe,Randomised,gLOBal Adaptive pLatform Trial for Stroke(ACT-GLOBAL) NCT06352632

NCT07687056 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT07687056
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07687056 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicentre,Prospective,Randomized,Open Label,Blinded-endpoint Trial for Reperfusion Enhancement After Completing Thrombectomy Using Intraarterial Thrombolysis(REACT-IA-Thrombolysis Domain)Embedded in A Multi-faCtorial,mulTi-arm, Multi-staGe,Randomised,gLOBal Adaptive pLatform Trial for Stroke(ACT-GLOBAL) NCT06352632
Lead sponsor
University of Calgary
Phase
Phase 3
Overall status
Not yet recruiting
Start date
June 10, 2026
Completion date
March 31, 2031
Enrollment
1,500 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

acute ischemic stroke ais, endovascular thrombectomy, stroke, acute ischemic